Description du poste
The University of Exeter is inviting applications for an Alzheimer’s Research UK-funded PhD studentship, starting on 1st February 2027 or as soon as possible thereafter. The studentship will cover UK tuition fees plus an annual tax-free stipend of at least £21,805 for four years full-time. Background to the project Dysfunction of the brain’s immune system is a major contributor to Alzheimer’s disease (AD) and other dementias. Recent studies have shown that gamma oscillations – a specific type of rhythmic electrical brain activity – can activate microglia, the brain’s immune cells, and promote the clearance of harmful substances such as amyloid-beta (Aβ) peptide. This response, which we refer to as Gamma Activity-Induced Neuron-microglia Signalling (GAINS), represents a promising therapeutic avenue for AD, but the underlying mechanisms remain poorly understood. Study design The project will combine several complementary techniques in mouse and human models to investigate the mechanisms underlying GAINS and explore their therapeutic potential for AD. Identifying molecular mechanisms of GAINS You will use electrophysiological recordings of gamma activity, two-photon imaging of microglia, optogenetics, and targeted pharmacology to identify molecular mediators of GAINS in mouse brain tissue. You will also investigate whether focused ultrasound stimulation – a technique with promising therapeutic potential for AD – can activate GAINS through similar mechanisms. Investigating GAINS in human brain tissue Through a secondment at the University of Edinburgh, you will investigate whether GAINS pathways identified in mouse tissue are conserved in humans. This will involve applying our model to living human brain tissue. Evaluating the therapeutic potential of GAINS Finally, you will use a mouse model of AD to investigate whether short- and long-term activation of GAINS pathways enhances microglial clearance of Aβ. The project has been developed through discussion with people with lived experience of dementia. You will have opportunities to engage with these individuals to gather their perspectives. Expected outcomes This research will reveal mechanisms underlying GAINS and establish whether pharmacological approaches or focused ultrasound can activate these pathways. The findings will provide evidence to support the development of new interventions targeting brain activity-immune system interactions, with the ultimate aim of slowing or modifying the progression of AD. Eligibility and funding The studentship will be awarded on the basis of academic merit. The conditions for eligibility of Home fees status are complex, and you will need to seek advice if you have moved to or from the UK (or Republic of Ireland) within the past 3 years or have applied for settled status under the EU Settlement Scheme. Students who pay international fees are eligible to apply. However, please note the following: The award covers only part of the international tuition fee, which is approximately £25,000. International applicants will need to cover additional costs, including student visa fees , Immigration Health Surcharge, and relocation expenses associated with moving to the UK to undertake a PhD. Funding Details UK tuition fees and an annual tax-free stipend of at least £21,805 per year.